Progesterone+ References

  1. Baerwald AR et al. Form and function of the corpus luteum during the human menstrual cycle. Ultrasound Obstet Gynecol. 2005; 25(5): 498-507.
  2. Seifert-Klauss V and Prior JC. Progesterone and bone: Actions promoting bone health in women. J Osteoporos. 2010; 2010: 845180.
  3. Lei B et al. Anti-inflammatory effects of progesterone in lipopolysaccharide-stimulated BV-2 microglia. PLoS One. 2014; 9(7): e103969.
  4. Li Y et al. Progesterone alleviates endometriosis via inhibition of uterine cell proliferation, inflammation, and angiogenesis in an immunocompetent mouse model. PLoS One. 2016; 11(10): e0165347.
  5. Pengo MF et al. Sleep in women across the life span. Chest. 2018; 154(1): 196-206.
  6. Moore LB et al. Orphan Nuclear Receptors Constitutive Androstane Receptor and Pregnane X Receptor Share Xenobiotic and Steroid Ligands. J Biol Chem. 2000; 275(20): 15122-15127.
  7. Turkmen S et al. Tolerance to allopregnanolone with focus on the GABA-A receptor. Br J Pharmacol. 2011; 162(2): 311-327.
  8. Pinna G et al. Allopregnanolone (1938–2019): A trajectory of 80 years of outstanding scientific achievements. Neurobiol Stress. 2020; 100246.
  9. Roomruangwong C et al. Lowered steady-state plasma levels of progesterone combined with declining progesterone levels during the luteal phase predict peri-menstrual syndrome and its major subdomains. Front Psychol. 2019; 10: 2446.
  10. Roomruangwong C et al. The menstrual cycle may not be limited to the endometrium but also may impact gut permeability. Acta Neuropsychiatrica 2019.
  11. Cable JK and Grider MH. Progesterone physiology. StatPearls.2021.
  12. Prior JC. Progesterone for Symptomatic Perimenopause Treatment – Progesterone politics, physiology and potential for perimenopause. Facts Views Vis Obgyn. 2011; 3(2): 109-120.
  13. Datta M et al. Thyroid hormone stimulates progesterone release from human luteal cells by generating a proteinaceous factor. J Endocrinol. 1998; 158(3): 319-325.
  14. Takahashi N et al. A potential role for endoplasmic reticulum stress in progesterone deficiency in obese women. Endocrinol. 2017; 158(1): 84-97.
  15. Fucic A et al. Environmental exposure to xenoestrogens and oestrogen related cancers: reproductive system, breast, lung, kidney, pancreas, and brain. Environ Health. 2012; 11(Suppl 1): S8.
  16. Grantham JP et al. The estrogen hypothesis of obesity. PLoS One. 2014.
  17. Progestin (oral route, parenteral route, vaginal route). Mayo Clinic. Updated Sept 1, 2021. Accessed Sept 29, 2021.
  18. Paulson RJ et al. Progesterone pharmacokinetics and pharmacodynamics with 3 dosages and 2 regimens of an effervescent micronized progesterone vaginal insert. J Clin Endocrinol Metab. 2014; 99(11): 4241-4249.